Answers are grounded in this paper and cite their sources.
Background: Gastric cancers represent a significant public health burden and one of the main causes of gastrointestinal cancer morbidity and mortality. Further elucidation of pathogenic subsets of these cancers may help the development of efficacious targeted therapies. Methods: The gastric adenocarcinoma cohort of the Cancer Genome Atlas (TCGA) was the basis of an analysis of gastric cancers with putative deep deletions at the WWOX locus. Gastric cancers with such putative deep deletions were compared with gastric cancers without putative deep WWOX deletions for clinical and genomic properties and survival outcomes. Results: Putative deep deletions of WWOX were observed in 31.7% of gastric cancers in the TCGA cohort. Compared with putative WWOX non-deep-deleted cancers, gastric cancers with putative WWOX deep deletions possessed more frequently microsatellite instability and a high tumor mutation burden (TMB). TP53 mutations and chromosomal instability were not more frequent in WWOX putative deep deleted gastric cancers. After exclusion of the MSI-high subset, WWOX putative deep deleted cancers presented more frequent markers of chromosomal instability than putative WWOX non-deep-deleted cancers, while the prevalence of high TMB did not differ between the groups. Putative deep deletions in other common fragile sites (CFSs) showed higher prevalence in WWOX putative deep deleted gastric cancers compared with WWOX non-deep-deleted gastric cancers. Conclusions: Putative deep deletions of WWOX are frequent in gastric adenocarcinomas and define a subset with more common MSI and higher frequency of observed putative deep deletions in additional CFSs.
No takes yet. Share an insight, caveat, or question.
Ioannis A. Voutsadakis (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: